F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comTempus AI Inc is a notable player in the artificial intelligence-driven healthcare and biotechnology sector. With its rapid advancements in AI-based medical solutions, investors are keen to analyze Tempus AI Inc's share price trajectory from 2025 to 2030. This blog provides an insightful analysis based on current market statistics, expert predictions, and expected growth trends.
Before delving into future share price targets, let's look at the latest stock details of Tempus AI Inc:
Previous Close: $45.58
Open: $48.72
Bid: $45.14 x 1900
Ask: $45.58 x 400
Day's Range: $44.16 - $49.60
52-Week Range: $22.89 - $91.45
Volume: 11,444,285
Avg. Volume: 12,389,781
Market Cap (Intraday): $7.836B
EPS (TTM): -$6.23
% of Shares Held by Insiders: 47.69%
% of Shares Held by Institutions: 34.25%
% of Float Held by Institutions: 65.47%
Number of Institutions Holding Shares: 199
Based on market trends, financial performance, and industry growth, the projected share price targets for Tempus AI Inc are:
| Year | Share Price Target ($) |
|---|---|
| 2025 | 50 - 70 |
| 2026 | 65 - 85 |
| 2027 | 80 - 110 |
| 2028 | 100 - 130 |
| 2029 | 120 - 160 |
| 2030 | 140 - 190 |
These projections reflect Tempus AI Inc's commitment to AI-driven healthcare innovations and its growing market share.
In 2025, Tempus AI Inc is expected to experience steady growth, with a share price range of $50 to $70. The primary reasons for this include:
Expansion of AI-driven medical diagnostics.
Increased adoption of precision medicine.
Strong institutional investment.
For 2026, the share price is projected to rise between $65 and $85, driven by:
Expansion into global healthcare markets.
New AI healthcare partnerships.
Advancements in personalized medicine.
In 2027, Tempus AI Inc is expected to witness a significant boost, with a projected price range of $80 to $110, owing to:
Breakthroughs in AI-based clinical research.
Increased revenue from healthcare data analytics.
Enhanced regulatory approvals for AI-powered solutions.
By 2028, the share price could reach $100 to $130, as the company strengthens its technological infrastructure and expands further into AI healthcare solutions.
A bullish trend is expected in 2029, with a projected price range of $120 to $160, fueled by:
Stronger revenue from AI-driven medical innovations.
Entry into new global healthcare markets.
Increased institutional investments.
By 2030, the share price is expected to reach $140 to $190, reflecting the company’s dominance in AI-powered healthcare solutions and its continuous innovation in the field.
Tempus AI Inc’s increasing focus on AI and machine learning in the medical sector will drive its share price growth.
A high percentage of institutional shareholding (65.47%) indicates strong investor confidence.
The rising global demand for AI-based medical solutions will enhance Tempus AI Inc’s revenue streams.
The company’s focus on AI-driven diagnostics, precision medicine, and biotechnology will be key growth factors.
The estimated share price target for 2025 is $50 to $70.
By 2030, the share price is expected to be $140 to $190.
Key drivers include AI innovation in healthcare, increased institutional investments, and expanding market reach.
Risks include competition, regulatory changes, and financial sustainability due to its negative EPS (-$6.23 TTM).
Tempus AI Inc presents a promising investment opportunity in the AI-driven healthcare sector. With a projected share price growth from $50 in 2025 to $190 in 2030, the company showcases strong potential. However, investors should consider market trends, risks, and technological advancements before making investment decisions.
As AI continues to revolutionize healthcare, Tempus AI Inc is set to play a key role in this transformation, making it a stock worth watching for the coming years.
Register & Login